Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Secondary Active Transport
Secondary Active Transport
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
David Z I Cherney1, Jacob A Udell2
1From Division of Nephrology, Department of Medicine (D.Z.I.C.) and Peter Munk Cardiac Centre (J.A.U.), Toronto General Hospital, Toronto, ON, Canada; Department of Physiology, Banting and Best Diabetes Centre (D.Z.I.C.) and Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research, Department of Medicine (D.Z.I.C., J.A.U.), University of Toronto, Toronto, ON, Canada; and Women's College Research Institute and Cardiovascular Division, Department of Medicine, Women's College Hospital, Toronto, ON, Canada (J.A.U.).
No abstract available in PubMed .